Oncology PracticeNovel PARP inhibitor boosts PFS in HER2- breast cancer with BRCA mutationsDecember 11, 2017Breast Cancer
Oncology PracticeExtra years of adjuvant bisphosphonate not needed in early breast cancerDecember 11, 2017Breast CancerPatient & Survivor Care
Hematology NewsVIDEO: CAR T cell axi-cel drives B-cell lymphomas into remissionDecember 11, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersImmuno-oncologyFollicular LymphomaB Cell Lymphoma
Hematology NewsThree-month response to CAR T-cells looks durable in DLBCLDecember 11, 2017Transfusion MedicineAggressive LymphomasImmuno-oncologyLymphoma & Plasma Cell Disorders
Hematology NewsCLL drug combinations induce MRD negativityDecember 11, 2017CLLLymphoma & Plasma Cell Disorders
Oncology PracticeVIDEO: CTCs may identify asymptomatic late breast cancer recurrencesDecember 11, 2017Breast Cancer
Hematology NewsActivating the Immune System to Treat Multiple MyelomaDecember 11, 2017Multiple Myeloma
Oncology PracticeMACRA Monday: BMI screening and follow-upDecember 11, 2017Business of MedicinePractice Management
Hematology NewsMAVORIC: Mogamulizumab tops vorinostat in pretreated CTCLDecember 10, 2017T Cell LymphomasLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology NewsCLARITY: Ibrutinib/venetoclax combo results look promising for relapsed/refractory CLLDecember 10, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsUpdated ZUMA-1 data show durable CAR-T responses in B-cell lymphomasDecember 10, 2017Aggressive LymphomasCellular TherapyIndolent LymphomaLymphoma & Plasma Cell DisordersImmunotherapyImmuno-oncologyFollicular Lymphoma
Hematology NewsGuideline preview: ASH to recommend against VTE prophylaxis for lower-risk cancer patientsDecember 10, 2017Thrombosis
Hematology NewsAvapritinib yields high response rate in patients with systemic mastocytosisDecember 10, 2017Myelodysplastic SyndromeMantle Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsIntrabone gene therapy shows promise in beta-thalassemiaDecember 10, 2017Bleeding Disorders
Hematology NewsGene therapy normalized or near-normalized factor VIII in hemophilia ADecember 10, 2017Bleeding Disorders
